Phathom Pharmaceuticals Statistics
Total Valuation
PHAT has a market cap or net worth of $442.40 million. The enterprise value is $708.98 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, before market open.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PHAT has 68.38 million shares outstanding. The number of shares has increased by 23.18% in one year.
Current Share Class | 68.38M |
Shares Outstanding | 68.38M |
Shares Change (YoY) | +23.18% |
Shares Change (QoQ) | +9.93% |
Owned by Insiders (%) | 3.79% |
Owned by Institutions (%) | 70.57% |
Float | 55.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.55 |
Forward PS | 2.68 |
PB Ratio | -1.78 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 12.83 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.20
Current Ratio | 4.20 |
Quick Ratio | 3.92 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.85 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -43.78% |
Return on Invested Capital (ROIC) | -51.42% |
Return on Capital Employed (ROCE) | -94.83% |
Revenue Per Employee | $129,396 |
Profits Per Employee | -$782,965 |
Employee Count | 427 |
Asset Turnover | 0.14 |
Inventory Turnover | 3.61 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.27% in the last 52 weeks. The beta is 0.64, so PHAT's price volatility has been lower than the market average.
Beta (5Y) | 0.64 |
52-Week Price Change | -40.27% |
50-Day Moving Average | 5.87 |
200-Day Moving Average | 10.94 |
Relative Strength Index (RSI) | 59.60 |
Average Volume (20 Days) | 1,378,051 |
Short Selling Information
The latest short interest is 14.36 million, so 21.00% of the outstanding shares have been sold short.
Short Interest | 14.36M |
Short Previous Month | 13.92M |
Short % of Shares Out | 21.00% |
Short % of Float | 25.79% |
Short Ratio (days to cover) | 11.78 |
Income Statement
In the last 12 months, PHAT had revenue of $55.25 million and -$334.33 million in losses. Loss per share was -$5.29.
Revenue | 55.25M |
Gross Profit | 47.28M |
Operating Income | -277.47M |
Pretax Income | -297.11M |
Net Income | -334.33M |
EBITDA | -276.67M |
EBIT | -277.47M |
Loss Per Share | -$5.29 |
Full Income Statement Balance Sheet
The company has $297.26 million in cash and $554.95 million in debt, giving a net cash position of -$257.69 million or -$3.77 per share.
Cash & Cash Equivalents | 297.26M |
Total Debt | 554.95M |
Net Cash | -257.69M |
Net Cash Per Share | -$3.77 |
Equity (Book Value) | -253.58M |
Book Value Per Share | -3.70 |
Working Capital | 274.41M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$266.77 million and capital expenditures -$135,000, giving a free cash flow of -$266.91 million.
Operating Cash Flow | -266.77M |
Capital Expenditures | -135,000 |
Free Cash Flow | -266.91M |
FCF Per Share | -$3.90 |
Full Cash Flow Statement Margins
Gross Margin | 85.57% |
Operating Margin | -502.18% |
Pretax Margin | -605.09% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PHAT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.18% |
Shareholder Yield | n/a |
Earnings Yield | -74.08% |
FCF Yield | -59.14% |
Analyst Forecast
The average price target for PHAT is $23.00, which is 255.49% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $23.00 |
Price Target Difference | 255.49% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 78.70% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
PHAT has an Altman Z-Score of -5.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.4 |
Piotroski F-Score | 3 |